Daewoong Pharmaceutical's Nabota (botulinum toxin type A) has surpassed 1 trillion won (approximately $750 million USD) in cumulative lifetime sales, underscoring the maturation and scale of the Asian aesthetics market. Nabota is the leading botulinum toxin in South Korea and has expanded into other Asian markets, competing against Botox and Dysport on price and local market knowledge.
Market
Daewoong's Nabota Hits 1 Trillion Won in Cumulative Sales—Asian Toxin Market Matures
South Korean botulinum toxin reaches milestone as Asian aesthetics market consolidates around regional players.
1-YEAR MOVE
ABBV▲11.6%
| Ticker | Company | 1-year change |
|---|---|---|
| ABBV | AbbVie (Allergan Aesthetics) | +11.6% |
1 trillion won in cumulative sales demonstrates the scale of regional toxin markets outside the U.S.
The milestone reflects a structural reality: non-Western markets are developing robust, locally-manufactured neuromodulator and filler ecosystems that compete on cost and regulatory familiarity. For U.S. practice owners, this signals that global supply chains for injectables are diversifying. If Asian manufacturers continue to gain share in their home markets, they will eventually seek U.S. entry—either through FDA approval or acquisition by larger players. Practitioners should view this as a long-term competitive pressure on pricing and a reminder that the AbbVie-Galderma duopoly is not inevitable.
Source: original report ↗
Free alerts
Free: recall & rule-change alerts for your practice.
Get the recalls and state-law changes that hit your treatment room, in your inbox — free. Unsubscribe in one click.
Free · weekly · unsubscribe anytime. Privacy.
Stay three moves ahead of every practice in your market.
Knowing it happened is table stakes. Inside MedSpa Pro hands you the play — what each move means for your margins, your license, and your patients, and exactly what to do about it — in a two-minute brief, twice a week. The owners who read it never get blindsided.
Get the edge · $20/moJoin the owners who run ahead of the industry. Cancel anytime, one click.